Chemoinformaics analysis of 3-Methyl-1-penten-3-ol
| Molecular Weight | 100.161 | nRot | 2 |
| Heavy Atom Molecular Weight | 88.065 | nRig | 4 |
| Exact Molecular Weight | 100.089 | nRing | 0 |
| Solubility: LogS | -6.141 | nHRing | 0 |
| Solubility: LogP | 7.072 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 18.8235 |
| nHD | 1 | BPOL | 12.0385 |
| QED | 0.2 |
| Synth | 2.401 |
| Natural Product Likeliness | 0.603 |
| NR-PPAR-gamma | 0.806 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.304 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.723 |
| MDCK | 0.0000173 |
| BBB | 0.263 |
| PPB | 0.948364 |
| VDSS | 3.472 |
| FU | 0.00981674 |
| CYP1A2-inh | 0.372 |
| CYP1A2-sub | 0.192 |
| CYP2c19-inh | 0.436 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.285 |
| CYP2c9-sub | 0.924 |
| CYP2d6-inh | 0.105 |
| CYP2d6-sub | 0.067 |
| CYP3a4-inh | 0.656 |
| CYP3a4-sub | 0.095 |
| CL | 5.498 |
| T12 | 0.266 |
| hERG | 0.107 |
| Ames | 0.004 |
| ROA | 0.012 |
| SkinSen | 0.958 |
| Carcinogencity | 0.078 |
| EI | 0.908 |
| Respiratory | 0.736 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.956833 |